Skip to main content

Diabetes

  • Spherix's Type 2 diabetes drug caused 'significant drop' in patients' HbA1c levels

    BETHESDA, Md. Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when taking an investigational treatment for Type 2 diabetes made by Spherix, the biotechnology company said Thursday.

     

    Spherix announced results of a phase-3 trial of D-tagatose, which showed that the drug was more effective in American patients than in Indian patients.

     

     

  • Hyperglycemia could cause Type 2 diabetes in acutely ill patients, study finds

    NEW YORK Heightened blood sugar during critical illnesses could be a sign of risk for Type 2 diabetes, according to a recent study by researchers in Croatia.

     

  • Gestational diabetes test may predict Type 2 diabetes among women

    TEL AVIV, Israel A new Tel Aviv University study found a test used to diagnose gestational diabetes in women could be a key indicator to diagnosing Type 2 diabetes.

  • Bret Michaels tapped for Stop Diabetes campaign

  • Novo Nordisk joins the Diabetes Prevention and Control Alliance

  • UltiMed names VP diabetes care

    ST. PAUL, Minn. UltiMed, a company that makes insulin-delivery devices, has named a new executive.

     

    The company announced the appointment of Brahim Zabeli as VP diabetes care for the U.S. market. In the new role, Zabeli will manage commercial activity, including sales, marketing and customer service.

     

     

    Zabeli previously worked as director of trade and managed markets for medical supply company Becton, Dickinson & Co.

     

  • Air pollution may be linked to diabetes, study finds

    BOSTON Diabetes could partially be related to air pollution, according to a new study.

     

    The study, conducted by researchers at Children’s Hospital Boston and published in this month’s issue of the journal Diabetes Care, found that diabetes in adults was consistently correlated with particulate air pollution even after adjusting for known risk factors, such as obesity and ethnicity.

     

     

  • Suppliers take steps to address women’s needs

    The opportunity within foot care may be even more skewed toward the female shopper than in years past when insoles and devices designed with the woman in mind were first introduced.

    The fact is, men and women are in search of satisfying different needs when considering a foot care product purchase. Men are more utilitarian, preferring high-function products that offer extra-cushioning, support and comfort. Women, meanwhile, shop for products that complement not only their feet and their shoes, but also their busy lifestyles, according to Implus Footcare research.

X
This ad will auto-close in 10 seconds